electroCore (ECOR) Equity Ratio (2017 - 2026)
electroCore's quarterly Equity Ratio came in at 0.37 in Q1 2026, down 235.01% year-on-year from 0.27 in Q1 2025, and down 301.3% quarter-over-quarter from 0.09 in Q4 2025.
electroCore has reported Equity Ratio for 10 years, with the latest figure at 0.37 in Q1 2026.
- For the quarter ending Q1 2026, Equity Ratio fell 235.01% year-over-year to 0.37; the trailing twelve-month figure through Mar 2026 stood at 0.37 (down 235.01% YoY), and the FY2025 full-year result was 0.09, down 124.84% from the prior year.
- Equity Ratio for Q1 2026 stood at 0.37, down from 0.09 in the prior quarter.
- The five-year high for Equity Ratio was 0.86 in Q1 2022, with the low at 0.37 in Q1 2026.
- Average Equity Ratio over 5 years is 0.4, with a median of 0.46 recorded in 2023.
- Year-over-year, Equity Ratio rose 8.3% in 2022 and sank 235.01% in 2026.
- Tracing ECOR's Equity Ratio over 5 years: stood at 0.69 in 2022, then sank by 33.03% to 0.46 in 2023, then slipped by 20.26% to 0.37 in 2024, then tumbled by 124.84% to 0.09 in 2025, then sank by 301.3% to 0.37 in 2026.
- The last three Equity Ratio figures came in at 0.37 (Q1 2026), 0.09 (Q4 2025), and 0.05 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.47 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.50 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.54 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.59 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.78 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.45 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.29 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.67 |
| 10 | electroCore | 92,394.96 | -8.79 Mn | 8.36 Mn | -0.37 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.37 |
| Dec 31, 2025 | -0.09 |
| Sep 30, 2025 | -0.05 |
| Jun 30, 2025 | 0.08 |
| Mar 31, 2025 | 0.27 |
| Dec 31, 2024 | 0.37 |
| Sep 30, 2024 | 0.45 |
| Jun 30, 2024 | 0.51 |
| Mar 31, 2024 | 0.32 |
| Dec 31, 2023 | 0.46 |
| Sep 30, 2023 | 0.55 |
| Jun 30, 2023 | 0.50 |
| Mar 31, 2023 | 0.65 |
| Dec 31, 2022 | 0.69 |
| Sep 30, 2022 | 0.75 |
| Jun 30, 2022 | 0.81 |
| Mar 31, 2022 | 0.86 |
| Dec 31, 2021 | 0.86 |
| Sep 30, 2021 | 0.86 |
| Jun 30, 2021 | 0.79 |
| Mar 31, 2021 | 0.79 |
| Dec 31, 2020 | 0.75 |
| Sep 30, 2020 | 0.78 |
| Jun 30, 2020 | 0.75 |
| Mar 31, 2020 | 0.67 |
| Dec 31, 2019 | 0.70 |
| Sep 30, 2019 | 0.73 |
| Jun 30, 2019 | 0.83 |
| Mar 31, 2019 | 0.85 |
| Dec 31, 2018 | 0.90 |
| Sep 30, 2018 | 0.94 |
| Jun 30, 2018 | 0.93 |
| Dec 31, 2017 | -2.28 |